epiretinal membrane, n = 8
Disclosure of interest: Dr Rohid Zamani: Nothing to disclose, Dr Daniel McWilliams: nothing to disclose, Dr Sameer Limaye: Nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P2566 - ESOC25-2302 CEREBRAL SALT-WASTING SYNDROME IN PATIENTS WITH ACUTE ISCHEMIC STROKE: A NARRATIVE LITERATURE REVIEW Nikolaos Faraklas Perdikouris 1 , Athanasios Vasilopoulos 2 , Athanasios Mitsias 1 , Panayiotis Mitsias 1,3,4 1 School of Medicine, University of Crete, Heraklion, Greece, 2 University Hospital of Lyon, Lyon, France, 3 University Hospital of Heraklion, Heraklion, Greece, 4 Department of Neurology, Henry Ford Hospital, Detroit, United States Background and Aims: Hyponatremia is a common complication of acute stroke and may be the result of inappropriate ADH Secretion (SIADH) or cerebral salt-wasting syndrome (CSWS)
F.BaggioniA
How to Calculate Your Sermorelin Dose Calculating your dose requires understanding the relationship between your vial concentration, syringe units, and desired mcg dose
Bacterial cultures, or an equivalent volume of 10% (v/v) FBS-HI in Brucella broth (mock infection control), were diluted in co-culture medium (DMEM or RPMI 1640 supplemented with 10% (v/v) Brucella broth and 5% (v/v) FBS-HI) to achieve an MOI of 35 or 50